Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Petot, Grace J.a; * | Vega, Ursulac | Traore, Fatoumatad | Fritsch, Thomasb; d | Debanne, Sara M.e | Friedland, Robert P.b | Lerner, Alan J.b
Affiliations: [a] Department of Nutrition, School of Medicine, Case Western Reserve University, Cleveland, OH, USA | [b] Department of Neurology, School of Medicine, Case Western Reserve University, Cleveland, OH, USA | [c] Alzheimer's Disease Center, Institute of Psychiatry, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil | [d] University Memory and Aging Center, Case Western Reserve University-University Hospitals of Cleveland, Cleveland, OH, USA | [e] Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
Correspondence: [*] Authors for correspondence: Grace J. Petot, M.S., Assistant Professor Emerita, University Memory and Aging Center, 12200 Fairhill Road, Cleveland, OH 44120, USA. Tel.: +1 216 844 6335; Fax: +1 216 844 6339; E-mail: grace.petot@case.edu.
Abstract: The purpose of this study is to examine the relationship of height, Apolipoprotein E genotype (APOE) and Alzheimer's disease (AD). Using a case-control design, subjects were recruited from the research registry of the University Memory and Aging Center of Case Western Reserve University and University Hospitals of Cleveland. On entry to the study, height was measured on 239 probable or possible AD patients and 341 healthy controls living in northeast Ohio. Risk of AD was modeled as a function of quartile of height, APOE genotype, years of education and year of birth. Analyses were stratified by gender. For men, cases were more likely to be shorter when compared to controls (p=0.001). There was only a small difference in mean height between AD cases and controls among women (p=0.05). For men, height in the highest quartile [>179.7 cm (70.75 in)] had a 59% lower risk of developing AD that in the lowest quartile [< 169.5 cm (66.75 in)], controlling for year of birth, and education (p=0.03). For women without an APOE ε4 allele, increasing height was associated with lower risk for AD (OR=0.88; p=0.01) but no significant association was found for women with at least one ε4 allele (OR=1.03; p=0.56).
Keywords: Height, Alzheimer's disease, risk factors, mid-life
DOI: 10.3233/JAD-2007-11310
Journal: Journal of Alzheimer's Disease, vol. 11, no. 3, pp. 337-341, 2007
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl